Israel Englander Allovir, Inc. Transaction History
Millennium Management LLC
- $192 Billion
- Q4 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Allovir, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 3,033,782 shares of ALVR stock, worth $29.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,033,782
Previous 3,284,800
7.64%
Holding current value
$29.8 Million
Previous $2.66 Million
52.11%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ALVR
# of Institutions
49Shares Held
21.1MCall Options Held
41KPut Options Held
100-
Siren, L.L.C. New York, NY6.6MShares$64.9 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$26 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.91MShares$18.8 Million0.06% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ664KShares$6.53 Million0.0% of portfolio
-
Black Rock Inc. New York, NY634KShares$6.23 Million0.0% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $915M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...